Neste Oyj (LON:0O46)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,077	7,703	21,472	29,309	27,968	40,699
Market Cap Growth	-29.94%	-64.13%	-26.74%	4.79%	-31.28%	101.70%
Enterprise Value	12,878	11,092	23,401	30,649	28,319	40,968
Last Close Price	11.93	9.60	25.76	34.24	31.46	45.35
PE Ratio	-	-	17.27	17.50	18.80	63.80
PS Ratio	0.51	0.45	1.08	1.29	2.20	4.39
PB Ratio	1.47	1.26	2.92	3.97	4.77	7.66
P/TBV Ratio	1.62	1.38	3.18	4.26	5.15	8.02
P/FCF Ratio	24.57	-	28.25	-	31.27	34.15
P/OCF Ratio	6.24	7.87	10.86	27.61	16.70	22.08
EV/Sales Ratio	0.71	0.65	1.18	1.34	2.23	4.42
EV/EBITDA Ratio	16.88	19.16	11.80	12.04	13.78	32.27
EV/EBIT Ratio	-	705.93	16.11	14.42	16.74	43.14
EV/FCF Ratio	34.86	-	30.78	-	31.66	34.38
Debt / Equity Ratio	0.74	0.69	0.48	0.31	0.25	0.22
Debt / EBITDA Ratio	6.03	5.15	1.60	0.86	0.68	0.85
Debt / FCF Ratio	12.40	-	4.64	-	1.65	0.98
Asset Turnover	1.30	1.31	1.48	1.88	1.36	1.06
Inventory Turnover	5.30	5.93	5.49	6.94	5.34	4.55
Quick Ratio	0.79	0.79	1.05	0.88	1.01	1.24
Current Ratio	1.91	1.73	2.10	1.92	1.95	2.17
Return on Equity (ROE)	-2.57%	-1.20%	17.11%	24.70%	27.46%	12.05%
Return on Assets (ROA)	-0.27%	0.07%	6.77%	10.96%	11.32%	6.76%
Return on Capital (ROIC)	-0.34%	0.10%	8.91%	15.22%	15.76%	9.15%
Return on Capital Employed (ROCE)	-	0.20%	13.30%	21.80%	22.20%	14.00%
Earnings Yield	-1.78%	-1.02%	5.79%	5.71%	5.32%	1.57%
FCF Yield	4.07%	-3.67%	3.54%	-1.43%	3.20%	2.93%
Dividend Yield	4.92%	1.72%	4.04%	2.64%	2.19%	1.58%
Payout Ratio	-	-	81.51%	33.37%	34.67%	109.97%
Buyback Yield / Dilution	0.03%	-0.01%	0.01%	-0.00%	-0.00%	-0.01%
Total Shareholder Return	4.95%	1.71%	4.06%	2.64%	2.19%	1.57%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.